US Market Report for Declotting Devices 2017 - MedCore

  • ID: 3976174
  • Report
  • Region: United States
  • 48 pages
  • iData Research
1 of 5

FEATURED COMPANIES

  • Abbott
  • Artegraft
  • Boston Scientific
  • Fresenius
  • Medisystems
  • Nipro Medical
  • MORE
General Report Contents:

- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions

The Fistula First objective is to improve the quality of life and survival of hemodialysis patients through optimizing the selection of vascular access. The majority of patients will benefit most through AV fistula access. AV fistula lowers mortality rates, hospitalization and infection while minimizing costs. Increased AV fistula use will result in a greater demand for declotting device procedures. Peritoneal dialysis does not require the use of hemodialysis declotting devices. Thus, the trend towards peritoneal dialysis will erode the number of hemodialysis patients and the amount of hemodialysis equipment sold. The market share and use of hemodialysis declotting devices is projected to decrease proportional to the number of patients transitioning from hemodialysis to peritoneal dialysis.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Artegraft
  • Boston Scientific
  • Fresenius
  • Medisystems
  • Nipro Medical
  • MORE
Table Of Contents
List Of Figures
List Of Charts
Executive Summary
U.S. Dialysis Device Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History
Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring
Declotting Device Market
2.1 Introduction
2.2 Market Overview
2.3 Market Analysis And Forecast
2.3.1 Total Declotting Device Market
2.3.2 Mechanical Declotting Device Market
2.3.3 Embolectomy Balloon Market
2.4 Drivers And Limiters
2.4.1 Market Drivers
2.4.2 Market Limiters
2.5 Competitive Market Share Analysis
Abbreviations
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Artegraft
  • Boston Scientific
  • Fresenius
  • Medisystems
  • Nipro Medical
  • MORE
Lumen stenosis can occur due to the accumulation of thrombosis or plaque particles in a similar manner to peripheral arterial disease. The accumulation of these plaque particles has also been shown to cause calcification. Lumen stenosis is a considerable problem for both AV access surgical grafts and native fistulae because they have poor vessel patency. Due to their tendency to acquire blockages, AV access surgical grafts will require revascularization twice a year, and native fistulae will need to be cleared at least once a year.
Note: Product cover images may vary from those shown
5 of 5
  • Fresenius
  • Baxter
  • Rockwell Medical
  • Medivators
  • MarCor
  • Medisystems
  • B. Braun
  • Nipro Medical
  • Asahi Kasei Medical
  • Medcomp
  • Medtronic
  • Teleflex Medical
  • AmeriWater
  • Merit Medical Systems
  • C.R. Bard
  • Edwards Lifesciences
  • NxStage Medical
  • AngioDynamics
  • Tarumo
  • MEDRAD
  • W.L. Gore
  • Cook Medical
  • Kawasumi Laboratories
  • Lemaitre Vascular Inc.
  • Cordis
  • Boston Scientific
  • Abbott
  • Argon Medical
  • Atrium
  • Artegraft
  • Angelini Pharma Inc.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll